MDS

August 29, 2022

Blood cancer progression

Vanderbilt researchers used single-cell technologies to explore the accumulation of mutations during blood cancer progression, which could help identify strategies for preventing leukemia before it occurs.

By Leigh MacMillan

June 24, 2022

Schwartz receives V Foundation for Cancer Research award

The V Foundation for Cancer Research has awarded a $200,000 grant to Jason Schwartz, MD, PhD, assistant professor in the Division of Pediatric Hematology and Oncology, to support his studies of childhood myelodysplastic syndromes (MDS), bone marrow disorders that can lead to cancer. 

By Bill Snyder

September 24, 2020

VICC leading first global study of MDS/MPN overlap syndrome

Overlap syndromes are distinct blood cancers that present with features of both myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPN).

By Tom Wilemon